ロード中...
Azilsartan medoxomil in the management of hypertension: an evidence-based review of its place in therapy
BACKGROUND: Azilsartan (AZI) is a relatively new angiotensin receptor blocker available for the treatment of any stage of hypertension, which was eventually given in combination with chlorthalidone (CLT). OBJECTIVE: To review pharmacology and clinical role of AZI monotherapy and AZI/CLT or AZI/amlod...
保存先:
| 出版年: | Core Evid |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4829189/ https://ncbi.nlm.nih.gov/pubmed/27103882 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CE.S81776 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|